Could Buying This Stock Today Pay Off Big Over the Next 5 Years?

This healthcare giant is a top pick for growth and dividend investors.AbbVie (ABBV 0.31%) has delivered excellent returns over the past decade. It experienced a slight slowdown in recent years as it navigated the loss of patent exclusivity for its former best-selling medicine, Humira. Now that this patent cliff is in the rearview mirror, though, AbbVie's outlook for the next five years looks bright. Could investing in the pharmaceutical giant pay off over the next five years? I think so, and here is why.Two ...